USNYSE
Eli Lilly and Company (LLY)
Pharmaceutical company known for GLP-1 diabetes/obesity treatments.
USD 1,174.61
Current price
1.11T
Market cap
44.7%
Revenue growth
USD 22.95
EPS
DATA_UNAVAILABLE
FCF
51.2
P/E
DATA_UNAVAILABLE
Forward P/E
DATA_UNAVAILABLE
FCF margin